blog | Aevex

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

2026, Aevex, Kailera Therapeutics, Alamar Biosciences

IPO Class Opens With Strong Double-Digit Premiums as Follow-Through Proves Mixed, Led by AVEX Strength

Eric Friedman

Apr 17, 2026 6:17:03 PM

Friday’s IPO slate — Aevex Corp. (AVEX), Alamar Biosciences (ALMR), and Kailera Therapeutics (KLRA) ...

IPOs, NYSE, 2026, Aevex

AEVEX IPO Signals Next Wave of Defense Tech as Autonomy and AI Move to the Battlefield

Eric Friedman

Apr 9, 2026 1:38:33 PM

Subscribe to our Newsletter

Email

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.